Replies to post #72366 on Biotech Values

[DewDiligence]

Perhaps Lunesta users are finally recognizing that the drug is, by and large, no better than the other available choices for insomnia. Here’s an article from today’s Boston Globe:

http://www.boston.com/business/healthcare/articles/2009/01/29/sepracor_to_shift_focus_cut_530_jobs/